300015 Stock Overview
Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions.
Aier Eye Hospital Group Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CN¥43.65|
|52 Week High||CN¥70.20|
|52 Week Low||CN¥25.02|
|1 Month Change||24.29%|
|3 Month Change||36.02%|
|1 Year Change||-36.07%|
|3 Year Change||139.03%|
|5 Year Change||534.82%|
|Change since IPO||2,885.11%|
Recent News & Updates
|300015||CN Healthcare||CN Market|
Return vs Industry: 300015 underperformed the CN Healthcare industry which returned -31.2% over the past year.
Return vs Market: 300015 underperformed the CN Market which returned -6.8% over the past year.
|300015 Average Weekly Movement||7.2%|
|Healthcare Industry Average Movement||6.7%|
|Market Average Movement||7.2%|
|10% most volatile stocks in CN Market||10.2%|
|10% least volatile stocks in CN Market||5.1%|
Stable Share Price: 300015 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: 300015's weekly volatility (7%) has been stable over the past year.
About the Company
Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract.
Aier Eye Hospital Group Fundamentals Summary
|300015 fundamental statistics|
Is 300015 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|300015 income statement (TTM)|
|Cost of Revenue||CN¥7.57b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.45|
|Net Profit Margin||15.65%|
How did 300015 perform over the long term?See historical performance and comparison
0.3%Current Dividend Yield
Is 300015 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 1/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 300015?
Other financial metrics that can be useful for relative valuation.
|What is 300015's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 300015's PE Ratio compare to its peers?
|300015 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
300760 Shenzhen Mindray Bio-Medical Electronics
600763 Topchoice Medical
601607 Shanghai Pharmaceuticals Holding
000963 Huadong Medicine
300015 Aier Eye Hospital Group
Price-To-Earnings vs Peers: 300015 is expensive based on its Price-To-Earnings Ratio (96.6x) compared to the peer average (43.3x).
Price to Earnings Ratio vs Industry
How does 300015's PE Ratio compare vs other companies in the CN Healthcare Industry?
Price-To-Earnings vs Industry: 300015 is expensive based on its Price-To-Earnings Ratio (96.6x) compared to the CN Healthcare industry average (26.4x)
Price to Earnings Ratio vs Fair Ratio
What is 300015's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||96.6x|
|Fair PE Ratio||46.4x|
Price-To-Earnings vs Fair Ratio: 300015 is expensive based on its Price-To-Earnings Ratio (96.6x) compared to the estimated Fair Price-To-Earnings Ratio (46.4x).
Share Price vs Fair Value
What is the Fair Price of 300015 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 300015 (CN¥43.65) is trading below our estimate of fair value (CN¥48.63)
Significantly Below Fair Value: 300015 is trading below fair value, but not by a significant amount.
Price to Earnings Growth Ratio
PEG Ratio: 300015 is poor value based on its PEG Ratio (3.3x)
Discover undervalued companies
How is Aier Eye Hospital Group forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?
Future Growth Score6/6
Future Growth Score 6/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300015's forecast earnings growth (29.1% per year) is above the savings rate (3.2%).
Earnings vs Market: 300015's earnings (29.1% per year) are forecast to grow faster than the CN market (23.9% per year).
High Growth Earnings: 300015's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300015's revenue (22.7% per year) is forecast to grow faster than the CN market (17.5% per year).
High Growth Revenue: 300015's revenue (22.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300015's Return on Equity is forecast to be high in 3 years time (25.2%)
Discover growth companies
How has Aier Eye Hospital Group performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 300015 has a large one-off loss of CN¥963.0M impacting its March 31 2022 financial results.
Growing Profit Margin: 300015's current net profit margins (15.6%) are higher than last year (15.4%).
Past Earnings Growth Analysis
Earnings Trend: 300015's earnings have grown significantly by 27.3% per year over the past 5 years.
Accelerating Growth: 300015's earnings growth over the past year (15.1%) is below its 5-year average (27.3% per year).
Earnings vs Industry: 300015 earnings growth over the past year (15.1%) exceeded the Healthcare industry 8%.
Return on Equity
High ROE: 300015's Return on Equity (20.4%) is considered high.
Discover strong past performing companies
How is Aier Eye Hospital Group's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 300015's short term assets (CN¥6.9B) exceed its short term liabilities (CN¥6.0B).
Long Term Liabilities: 300015's short term assets (CN¥6.9B) exceed its long term liabilities (CN¥3.5B).
Debt to Equity History and Analysis
Debt Level: 300015 has more cash than its total debt.
Reducing Debt: 300015 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: 300015's debt is well covered by operating cash flow (207.1%).
Interest Coverage: 300015 earns more interest than it pays, so coverage of interest payments is not a concern.
Discover healthy companies
What is Aier Eye Hospital Group current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 300015's dividend (0.27%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.48%).
High Dividend: 300015's dividend (0.27%) is low compared to the top 25% of dividend payers in the CN market (1.92%).
Stability and Growth of Payments
Stable Dividend: 300015's dividend payments have been volatile in the past 10 years.
Growing Dividend: 300015's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (26.2%), 300015's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (22.7%), 300015's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Li Li (57 yo)
Mr. Li Li serves as a Non-Executive Non-Independent Director at ISEC Healthcare Ltd. since March 25, 2020. He serves as the Vice Chairman and Chief Executive Officer at Aier Eye Hospital Group Co., Ltd.si...
Experienced Board: 300015's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Aier Eye Hospital Group Co., Ltd.'s employee growth, exchange listings and data sources
- Name: Aier Eye Hospital Group Co., Ltd.
- Ticker: 300015
- Exchange: SZSE
- Founded: 2007
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: CN¥236.636b
- Shares outstanding: 5.42b
- Website: https://www.aierchina.com
Number of Employees
- Aier Eye Hospital Group Co., Ltd.
- New Century Mansion No. 198
- Hunan Province
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/07/02 00:00|
|End of Day Share Price||2022/07/01 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.